Ondansetron Teva

Ondansetron, the active ingredient in Ondansetron Teva, is a 5-HT3 receptor antagonist presented as a tablet for oral use. It treats nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adults and children. GNH USA supplies Ondansetron Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ondansetron Teva is a selective 5‑HT3 receptor antagonist used to prevent and treat nausea and vomiting in several clinical settings.

- Chemotherapy‑induced nausea and vomiting: helps reduce the frequency and severity of episodes. - Radiation‑induced nausea and vomiting: provides prophylactic control. - Post‑operative nausea and vomiting: reduces incidence after surgery. - Hyper‑emesis gravidarum: used off‑label in some regions to manage severe pregnancy‑related vomiting. - Anticipatory nausea: helps patients who have learned to feel nausea before treatment.

Side effects of ondansetron are generally mild and dose‑dependent, but they can vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: occasional bowel movement changes. - Diarrhoea: transient loose stools. - Fatigue: feeling of tiredness. - Dizziness: light‑headed sensations.

Serious or Rare Side Effects: - QT prolongation: cardiac rhythm changes that may lead to arrhythmia. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Serotonin syndrome: rare but potentially life‑threatening when combined with other serotonergic agents. - Hepatic dysfunction: elevated liver enzymes. - Vision changes: blurred vision or transient visual disturbances.

When using Ondansetron Teva, certain precautions should be observed to ensure safe and effective therapy.

- Cardiac monitoring: patients with known QT prolongation or electrolyte abnormalities should be monitored. - Drug interactions: review concomitant medications for serotonergic activity. - Pregnancy: use only if the potential benefit outweighs the risk. - Breastfeeding: assess risk versus benefit before use. - Renal or hepatic impairment: dose adjustment may be required. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ondansetron may interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Apomorphine: may cause profound hypotension and loss of consciousness. - Certain anti‑arrhythmic drugs (e.g., quinidine, amiodarone): increase risk of QT prolongation. - Serotonergic agents (including SSRIs, SNRIs, MAOIs): heightened risk of serotonin syndrome.

Moderate Interaction ( Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase ondocine ");